INS and Skeletal muscle atrophy: MOTS-c is involved in multiple pathophysiological processes, i.e., improving insulin sensitivity by modulating glucose and fatty acid metabolism, transmitting signals from the mitochondria to the nucleus, ameliorating skeletal muscle atrophy, and increasing physical activity 28, 30, 33.